Pharmaceutical giants like Johnson & Johnson as well as smaller startups are investing in psychedelic drug development, and both are pursuing FDA approval for their patented psilocybin formulations.
Articles on Psychedelic medications
Displaying all articles
From July 1, authorised psychiatrists will be able to prescribe MDMA and psilocybin in some circumstances. Here’s what we’re excited and concerned about.
An anthropology course explores how peoples and cultures around the world use nature-based medicines to heal.
Australia is the first country in the world to legalise the medical use of psychedelics. But without a public subsidy, few Australians will be able to afford them.
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
Top contributors
-
Professor of Neurology, University of California, San Francisco
-
Professor, Monash University
-
Professor, Monash University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Psychiatrist and Clinical Associate at The Centre of Mental Health, Swinburne University of Technology
-
Chair of Psychiatry, The University of Melbourne
-
University of Sydney
-
Professor of Anthropology, Western Illinois University
-
Senior research fellow, Monash University
-
Professor of Psychiatry, UNSW & Black Dog Institute, UNSW
-
Professor, School of Medicine, The University of Queensland
-
Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University